Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...

Shares of Palatin Technologies, Inc. (PTN) gained 16% on Monday after the company announces completion of patient enrollment in phase ...

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and ...

And as astute pet parents, we usually have a good idea of what these sounds mean: feed me, pet me, please let me in. But would you recognize the sound of a cat wheezing? If the answer is no, don’t ...

"Plus, anabolic steroids ... range from oral contraceptives to spironolactone. Next up is electrolysis, which May says is often suggested if the hair is grey, blonde, or ginger in colour. Though again ...

Low anti-TNF levels during infliximab or adalimumab maintenance treatment are linked to increased risk for treatment failure in pediatric CD.

Topics covered include the role of statins in the management of inflammatory bowel disease ... and disease flares (marked by ...

Steritas LLC., a company dedicated to enhancing care for steroid-treated patients, today announced a licensing agreement with argenx, a global immunology company, for use of its STOX® Suite of steroid ...

Doron Therapeutics, a clinical-stage biotech company focusing on degenerative musculoskeletal conditions, today announced it has successfully raised an aggregate $11 million as an initial Series A ...